Effects on weight reduction and safety of short-term phentermine administration in Korean obese people - Wikidata - awgldk - TriplyDB

Effects on weight reduction and safety of short-term phentermine administration in Korean obese people

Effects on weight reduction and safety of short-term phentermine administration in Korean obese people

http://www.wikidata.org/entity/Q28201155

about

Weight management in obesity - past and present Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity Pharmacologic treatment options for obesity: what is old is new again.New pharmacological approaches for obesity management.Amphetamine-Like Analogues in Diabetes: Speeding towards Ketogenesis.Greater hunger and less restraint predict weight loss success with phentermine treatment.Postmarketing surveillance study of the efficacy and safety of phentermine in patients with obesity.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.Neuropsychiatric adverse effects of centrally acting antiobesity drugs.Anti-obesity drugs: a review about their effects and their safety.Do we need anti-obesity drugs?Update on obesity pharmacotherapy.Epidemiology of Obesity and Pharmacologic Treatment Options.Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.Addiction potential of phentermine prescribed during long-term treatment of obesity.The Science of Obesity Management: An Endocrine Society Scientific Statement.

P2860

Q26774747-6E80AE84-4A47-4283-BB99-3E91FFF14833 Q30400748-8D89AFC0-F13F-40B5-BF31-8EF6B8FC85BB Q33572190-80B40738-D3F5-4EBA-BA4D-C88275CA4097 Q34341681-D4DD6ADD-2B57-4EF2-B2B9-0576DFA2B484 Q34349850-822E2BA3-8148-4FA3-88A0-7F8FBBA1DCB3 Q34475880-DAF9A22F-282F-403F-BAC5-FE1404D87F3C Q36395927-A4872CFD-E610-4F33-A760-DC9F18F45A30 Q37217297-E6187BF1-332F-4DD6-8F1E-A027765B8081 Q37653402-B72A1B18-B09C-4A87-977F-9F8C9FBADE05 Q37779809-1D92B7B6-4B79-42B7-A238-CC2B6C7C6797 Q37939362-5FEA4871-F906-45CC-877D-A6372B265FEB Q37996099-01E47887-AD80-4B06-BBC2-E66A87226C9D Q38071006-D3125BD2-86CF-4C64-8CB6-78B8FB26616C Q38196951-8CC206A3-E35C-4CF9-A359-BE22CF9F433A Q38717129-39F13FBB-E994-48AD-8914-60FC342AE015 Q45140920-DA31214B-CE44-4BA4-A48F-0DADA909DDAB Q52302722-BAAFE360-0E1C-40DF-9DF8-6CD662CF4870 Q53438835-11ADCD60-F32B-4E8E-9E64-A074D55118BF

P2860

Effects on weight reduction and safety of short-term phentermine administration in Korean obese people

http://www.wikidata.org/entity/Q28201155

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Effects on weight reduction an ...... tration in Korean obese people

@ast

Effects on weight reduction an ...... tration in Korean obese people

@en

Effects on weight reduction an ...... tration in Korean obese people

@nl

type

label

Effects on weight reduction an ...... tration in Korean obese people

@ast

Effects on weight reduction an ...... tration in Korean obese people

@en

Effects on weight reduction an ...... tration in Korean obese people

@nl

prefLabel

Effects on weight reduction an ...... tration in Korean obese people

@ast

Effects on weight reduction an ...... tration in Korean obese people

@en

Effects on weight reduction an ...... tration in Korean obese people

@nl

P1433

Q28201155-6D35379E-8A3A-4CB2-994C-81688A9C2286

P1476

Q28201155-384ADA34-40C9-4784-9B33-5073D68B0812

P2093

Q28201155-38013160-7881-41E9-9828-1FD91DEB0CDC

Q28201155-59DAA1ED-8BBB-4588-8E51-5EABC912B490

Q28201155-B09245AC-3B7B-42D4-8CA2-B80827326B7D

Q28201155-DB6F435D-DF8C-4E77-9CF8-79EBCC4E7896

P2860

Q28201155-11C7439A-B4D1-4E02-8B48-2EA2BBD4C291

Q28201155-177CD6F0-B717-4920-AADE-40FF251D5297

Q28201155-18F49405-3ABB-4819-989F-0E0C86EB93B5

Q28201155-25BE7878-2B80-4610-B5B9-5D0DE0A3E9A5

Q28201155-44A91D97-2838-486F-837F-232964A21BEE

Q28201155-4A5A800C-3EFA-42F5-89D8-C856C653E140

Q28201155-4D6BE741-286E-4980-8556-41242C9FC310

Q28201155-7C4AF0DE-3CC4-41C7-95CF-E5247B0046FB

Q28201155-8713221A-3F07-42E8-ADCD-11AFD24567B4

Q28201155-9B9465E8-8E52-4660-9BAF-9E4F992EF8A2

P304

Q28201155-A55B17F6-2AA6-4328-BCF8-B905A8B93C0E

P31

Q28201155-BA672CA6-FC66-4CAE-98EF-A456D3A74A42

P356

Q28201155-B9942D27-1264-49F3-9428-4DAE7918128A

P407

Q28201155-5D6E9EB8-A551-4D97-B033-7BC1618414B1

P433

Q28201155-9409DDF1-5C3F-4DE5-B04B-0432FC02B851

P478

Q28201155-B5D10597-41B3-45CC-AA2F-34BE5B04C8FC

P50

Q28201155-CD053CA9-54FB-4801-8FE3-5A13EF3BBAF9

P577

Q28201155-DAA2B4FB-FF05-4CD5-83EB-A9A134611FD5

P5875

Q28201155-80223D9D-E53D-4CAA-8731-24B14006AC31

P698

Q28201155-FFD17E56-E642-4B17-A2AA-F84973DD77F9

P921

Q28201155-DF6B8EBE-BB27-4AE6-B462-94E7E89ABF86

P932

Q28201155-0A29C4D4-B089-41CD-A1BA-0C617B7BBAC1

P356

YMJ.2006.47.5.614

P1433

Yonsei Medical Journal

P1476

Effects on weight reduction an ...... tration in Korean obese people

@en

P2093

Bang-Bu Youn

http://www.w3.org/2001/XMLSchema#string

Hi-Jung Cho

http://www.w3.org/2001/XMLSchema#string

Kyoung Kon Kim

http://www.w3.org/2001/XMLSchema#string

Kyu-Rae Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.

Meta-analysis: pharmacologic treatment of obesity.

Pharmacological therapies for obesity.

Excess deaths associated with underweight, overweight, and obesity.

Body mass index and mortality in asian populations: implications for obesity cut-points.

Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats.

Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.

P304

614-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2006.47.5.614

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6728732

http://www.w3.org/2001/XMLSchema#string

P698

17066505

http://www.w3.org/2001/XMLSchema#string

P921

P932

2687747

http://www.w3.org/2001/XMLSchema#string